Skip to main content
. 2014 Apr 30;8(1):327–334. doi: 10.3892/ol.2014.2107

Table I.

Univariate and multivariate analysis of prognostic factors (n=268).

Univariate Multivariate


Variables n (%) P-value HR (95% CI) P-value HR (95% CI)
Gender 0.0003 1.72 (1.278–2.314) 0.577 1.106 (0.776–1.577)
 Male 186 (69)
 Female 82 (31)
Age, years 0.51 0.92 (0.703–1.192)
 >66 137 (51)
 <66 131 (49)
Smoking status 1.2×10−7 2.23 (1.659–3.409) 0.0009 1.86 (1.290–2.675)
 Never 87 (32)
 Ever 181 (68)
PS 4.1×10−5 2.02 (1.442–2.822) 5.6×10−6 2.21 (1.564–3.106)
 0–1 213 (79)
 2–3 55 (21)
Histology 0.0091 1.59 (1.123–2.261)
 Ad 220 (82)
 Non-Ad 48 (18)
Relapse following surgery 0.0017 1.77 (1.238–2.519) 1.48×10−5 2.28 (1.571–3.317)
 Yes 49 (18)
 No 219 (82)
Number of metastatic organs 0.0460 1.32 (1.005–1.732)
 1 161 (60)
 ≥2 107 (40)
Metastatic sites
 Intra-thoracic organs 0.0007 0.607 (0.456–0.810) 0.0009 0.593 (0.435–0.808)
  Yes 185 (69)
  No 83 (31)
 Abdominal organs 2.6×10−5 2.07 (1.474–3.649) 0.0006 1.88 (1.311–2.689)
  Yes 55 (21)
  No 213 (79)
 Brain 0.48 1.13 (0.807–1.584)
  Yes 55 (21)
  No 213 (79)
 Bone 0.0592 1.38 (0.997–1.899)
  Yes 58 (22)
  No 210 (78)
 Lymph nodes (distant) 0.6 1.12 (0.741–1.684)
  Yes 29 (11)
  No 239 (89)

Ad, adenocarcinoma; HR, hazard ratio; CI, confidence interval; PS, performance status.